简体中文 | 繁體中文 | English

Health and Pharmaceutical Press Releases

2016-09-22 16:12 OT Supplies SESAM-Vitale in France With More Than 7 Million Health Cards a Year
2016-09-22 15:57 SAB Biotherapeutics' Immunotherapy Proposal among Top Platform Technology Solutions in WHO Report
2016-09-21 16:19 Smith & Nephew Reinforces Strong Educational Commitment to Advanced Wound Management at World Union of Wound Healing Societies Meeting (WUWHS)
2016-09-21 10:50 Takeda and Zydus Cadila partner to address the global threat of Chikungunya
2016-09-21 10:37 New survey reveals 9 out of 10 patients with IPF were happy with how their doctor told them about their IPF diagnosis
2016-09-21 10:08 One-Year Results in Japanese Clinical Study Affirms the GORE® VIABAHN® Endoprosthesis as a Device-of-Choice for Treating Complex SFA Disease
2016-09-20 17:31 First Implant Completed in Pivotal Study of GORE® TAG® Thoracic Branch Endoprosthesis
2016-09-20 16:54 Second Global NCD Alliance Forum to be Held in Sharjah, UAE in December 2017
2016-09-20 10:40 Biopharmaceutical Industry Calls the Recommendations of UN High Level Panel on Access to Medicines a Missed Opportunity to Genuinely Address Patients’ Needs
2016-09-19 11:13 Oral Ozanimod Efficacy and Safety Results at 2 Years from Phase 2 RADIANCE Trial of Patients with Relapsing Multiple Sclerosis Presented at 32nd ECTRIMS
2016-09-19 11:08 Takeda Receives Positive CHMP Opinion for Conditional Approval of NINLAROTM (ixazomib), the First Oral Proteasome Inhibitor, for Use in Patients with Multiple Myeloma
2016-09-19 10:54 Glyxambi® (empagliflozin/linagliptin) approval recommended by CHMP for adults with type 2 diabetes in the European Union
2016-09-14 17:18 New LCP Monofilament Allows for MRI Guided Vascular Intervention
2016-09-13 10:32 Takeda Supports Global Expansion of the American Cancer Society’s Relay For Life (RFL)
2016-09-13 10:11 Samsung Bioepis' SB4 (BRENZYS™) Becomes First Etanercept Biosimilar to Receive Regulatory Approval in Canada
2016-09-12 09:57 Orphan Drug Designation Granted to Nintedanib for Treatment of Systemic Sclerosis, including Associated Interstitial Lung Disease
2016-09-09 16:23 Wake Up! One in Three Meeting Attendees are Falling Asleep
2016-09-09 14:28 Patient Safety Movement Foundation & Global Sepsis Alliance Join Forces to Reduce Preventable Deaths from Sepsis
2016-09-09 13:56 Ausupreme International Holdings Limited Announced Subscription Results for Hong Kong Public Offering
2016-09-08 14:48 New analysis showed dose adjustment of Giotrif® (afatinib) improved tolerability without an apparent impact on efficacy in patients with EGFR mutation-positive non-small cell lung cancer

Business Wire Weibo

Press Releases

Latest Releases